NANOHYBRIDS INC
Medtech · Private
Photodynamic therapy NanoDroplet (PtND): lipid-shelled nanoparticles containing oxygen-rich perfluorocarbon and photosensitizer dye for targeted drug delivery and photoacoustic imaging in wet age-rela
nanohybrids.net →- Grants
- $1.7M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $225K
- 1 award · Health and Human S
- #449 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ot::igf SBIR Topic 85 To Support The Development Of Target Specific Molecular Imaging Agents In Combination With Existing Imaging Modalities To Detect High Risk Atherosclerotic Plaque. | $224,973 | |
| Federal grant | Department of Health and Human Services · Phase I · Quantitative Photoacoustic Microscopy for Cancer Immunohistochemistry | $224,614 | |
| Federal grant | Department of Health and Human Services · Phase I · Quantitative Photoacoustic Microscopy for Cancer Immunohistochemistry | $224,614 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Delivery of Hydrophobic Chemotherapeutics via Laser-Initiated Nanosyringes | $149,992 | |
| Federal grant | Department of Health and Human Services · Phase I · Targeted Nanosyringe Delivery of miRNA Analogs to Subcutaneous Adipocytes for Treatment of Obesity | $272,243 | |
| Federal grant | Department of Health and Human Services · Phase I · Targeted Nanosyringe Delivery of miRNA Analogs to Subcutaneous Adipocytes for Treatment of Obesity | $272,243 | |
| Federal grant | Department of Health and Human Services · Phase I · Raising the Therapeutic Index of Photodynamic Therapy with Targeted Nanosyringes | $299,945 | |
| Federal grant | Department of Health and Human Services · Phase I · Enhancing Clinical Therapy for wet Age-related Macular Degeneration (wetAMD) | $297,786 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 446 | HealthMyne, Inc. | $225K | $19M |
| 447 | WINDTREE THERAPEUTICS, INC. | $225K | — |
| 448 | DETON CORP | $225K | — |
| 449 | NANOHYBRIDS INC | $225K | — |
| 450 | XILIS INC | $225K | $109M |
| 451 | PBS Biotech, Inc. | $224K | $43M |
| 452 | NIGHTWARE, INC | $213K | $2.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.